CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade MiMedx - MDXG CFD

    7.77
    0.26%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.06
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026207 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026207%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003985 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003985%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    MiMedx Group Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 7.74
    Open* 7.76
    1-Year Change* 153.59%
    Day's Range* 7.69 - 7.81
    52 wk Range 2.43-8.60
    Average Volume (10 days) 743.82K
    Average Volume (3 months) 13.26M
    Market Cap 839.08M
    P/E Ratio -100.00K
    Shares Outstanding 116.38M
    Revenue 309.02M
    EPS -0.02
    Dividend (Yield %) N/A
    Beta 1.62
    Next Earnings Date Feb 26, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Nov 29, 2023 7.74 0.01 0.13% 7.73 7.96 7.73
    Nov 28, 2023 7.86 0.19 2.48% 7.67 7.91 7.67
    Nov 27, 2023 7.89 0.47 6.33% 7.42 7.96 7.41
    Nov 24, 2023 7.53 0.03 0.40% 7.50 7.70 7.46
    Nov 22, 2023 7.53 0.54 7.73% 6.99 7.61 6.98
    Nov 21, 2023 7.19 0.17 2.42% 7.02 7.23 6.91
    Nov 20, 2023 7.13 0.32 4.70% 6.81 7.18 6.72
    Nov 17, 2023 7.02 0.51 7.83% 6.51 7.09 6.51
    Nov 16, 2023 6.67 0.28 4.38% 6.39 6.70 6.39
    Nov 15, 2023 6.57 0.19 2.98% 6.38 6.78 6.38
    Nov 14, 2023 6.66 0.47 7.59% 6.19 6.68 6.19
    Nov 13, 2023 6.13 0.40 6.98% 5.73 6.19 5.72
    Nov 10, 2023 5.91 0.25 4.42% 5.66 5.97 5.48
    Nov 9, 2023 5.67 -0.37 -6.13% 6.04 6.11 5.65
    Nov 8, 2023 6.06 -0.28 -4.42% 6.34 6.47 6.03
    Nov 7, 2023 6.45 -0.24 -3.59% 6.69 6.71 6.35
    Nov 6, 2023 6.66 -0.04 -0.60% 6.70 6.74 6.49
    Nov 3, 2023 6.78 0.44 6.94% 6.34 6.91 6.33
    Nov 2, 2023 6.46 0.06 0.94% 6.40 6.60 6.32
    Nov 1, 2023 6.42 0.04 0.63% 6.38 6.44 6.17

    MiMedx Events

    Time (UTC) Country Event
    Monday, February 26, 2024

    Time (UTC)

    10:59

    Country

    US

    Event

    Q4 2023 MiMedx Group Inc Earnings Release
    Q4 2023 MiMedx Group Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 267.841 258.615 248.234 299.255 359.111
    Revenue 267.841 258.615 248.234 299.255 359.111
    Cost of Revenue, Total 48.316 43.283 39.33 43.081 36.386
    Gross Profit 219.525 215.332 208.904 256.174 322.725
    Total Operating Expense 292.812 263.65 301.833 320.415 363.035
    Selling/General/Admin. Expenses, Total 207.546 196.081 177.606 193.982 252.628
    Research & Development 22.543 17.046 11.371 10.782 15.765
    Depreciation / Amortization 2.23 3.396 4.833 5.62 6.934
    Unusual Expense (Income) 12.177 3.844 68.693 66.95 51.322
    Operating Income -24.971 -5.035 -53.599 -21.16 -3.924
    Interest Income (Expense), Net Non-Operating -5.016 -4.98 -7.941 -4.708 0.527
    Net Income Before Taxes -29.991 -10.038 -61.543 -25.585 -3.397
    Net Income After Taxes -30.197 -10.285 -49.284 -25.58 -29.979
    Net Income Before Extra. Items -30.197 -10.285 -49.284 -25.58 -29.979
    Net Income -30.197 -10.285 -49.284 -25.58 -29.979
    Income Available to Common Excl. Extra. Items -36.777 -16.421 -83.328 -25.58 -29.979
    Income Available to Common Incl. Extra. Items -36.777 -16.421 -83.328 -25.58 -29.979
    Diluted Net Income -36.777 -16.421 -83.328 -25.58 -29.979
    Diluted Weighted Average Shares 112.909 110.353 108.257 106.946 105.596
    Diluted EPS Excluding Extraordinary Items -0.32572 -0.1488 -0.76972 -0.23919 -0.2839
    Diluted Normalized EPS -0.25562 -0.12616 -0.35727 0.16772 0.03201
    Total Extraordinary Items
    Other, Net -0.004 -0.023 -0.003 0.283
    Total Adjustments to Net Income -6.58 -6.136 -34.044
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 81.257 71.676 74.375 67.689 66.883
    Revenue 81.257 71.676 74.375 67.689 66.883
    Cost of Revenue, Total 13.583 12.419 14.369 12.188 11.823
    Gross Profit 67.674 59.257 60.006 55.501 55.06
    Total Operating Expense 78.469 75.057 73.308 74.792 76.519
    Selling/General/Admin. Expenses, Total 51.925 52.279 49.951 53.475 55.793
    Research & Development 8.497 6.496 5.4 5.953 5.512
    Depreciation / Amortization 0.191 0.19 0.182 0.175 0.173
    Unusual Expense (Income) 4.273 3.673 3.406 3.001 3.218
    Operating Income 2.788 -3.381 1.067 -7.103 -9.636
    Interest Income (Expense), Net Non-Operating -1.63 -1.553 -1.45 -1.27 -1.17
    Other, Net -0.032 0.002 -0.003 0 0
    Net Income Before Taxes 1.126 -4.932 -0.386 -8.373 -10.806
    Net Income After Taxes 1.2 -4.983 -0.414 -8.426 -10.868
    Net Income Before Extra. Items 1.2 -4.983 -0.414 -8.426 -10.868
    Net Income 1.2 -4.983 -0.414 -8.426 -10.868
    Total Adjustments to Net Income -1.728 -1.684 -1.696 -1.67 -1.628
    Income Available to Common Excl. Extra. Items -0.528 -6.667 -2.11 -10.096 -12.496
    Income Available to Common Incl. Extra. Items -0.528 -6.667 -2.11 -10.096 -12.496
    Diluted Net Income -0.528 -6.667 -2.11 -10.096 -12.496
    Diluted Weighted Average Shares 115.866 114.399 113.685 113.448 112.868
    Diluted EPS Excluding Extraordinary Items -0.00456 -0.05828 -0.01856 -0.08899 -0.11071
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS 0.01941 -0.03741 0.00091 -0.0718 -0.09218
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 134.198 148.523 160.617 123.245 74.049
    Cash and Short Term Investments 65.95 87.083 95.812 69.069 45.118
    Cash & Equivalents 65.95 87.083 95.812 69.069 45.118
    Short Term Investments
    Total Receivables, Net 43.788 41.096 45.468 32.345 0.454
    Accounts Receivable - Trade, Net 43.084 40.353 35.423 32.327
    Total Inventory 13.183 11.389 10.361 9.104 15.986
    Prepaid Expenses 8.646 6.146 5.605 6.669 6.673
    Other Current Assets, Total 2.631 2.809 3.371 6.058 5.818
    Total Assets 171.43 187.929 202.032 167.166 122.844
    Property/Plant/Equipment, Total - Net 11.256 13.861 15.06 15.725 17.424
    Property/Plant/Equipment, Total - Gross 47.183 46.739 44.558 39.702 35.782
    Accumulated Depreciation, Total -35.927 -32.878 -29.498 -23.977 -18.587
    Goodwill, Net 19.976 19.976 19.976 19.976 19.976
    Intangibles, Net 5.852 5.383 6.004 7.777 9.608
    Other Long Term Assets, Total 0.148 0.186 0.375 0.443 1.787
    Total Current Liabilities 43.557 42.357 59.162 67.322 71.547
    Accounts Payable 8.847 7.385 8.765 8.71 14.864
    Accrued Expenses 34.267 34.61 50.103 54.631 54.866
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 0.443 0.362 0.294 0.231 1.817
    Total Liabilities 96.924 95.353 110.614 132.768 73.189
    Total Long Term Debt 48.594 48.127 47.697 61.906 0
    Other Liabilities, Total 4.773 4.869 3.755 3.54 1.642
    Total Equity 74.506 92.576 91.418 34.398 49.655
    Redeemable Preferred Stock 92.494 92.494 91.568 0 0
    Common Stock 0.114 0.113 0.113 0.113 0.113
    Additional Paid-In Capital 173.804 165.695 158.61 147.231 164.744
    Retained Earnings (Accumulated Deficit) -191.906 -161.709 -151.424 -102.14 -76.56
    Treasury Stock - Common 0 -4.017 -7.449 -10.806 -38.642
    Total Liabilities & Shareholders’ Equity 171.43 187.929 202.032 167.166 122.844
    Total Common Shares Outstanding 113.705 111.925 110.93 110.819 109.099
    Total Preferred Shares Outstanding 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0 3.75
    Long Term Debt 48.594 48.127 47.697 61.906
    Preferred Stock - Non Redeemable, Net 0 0 0
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 154.502 141.223 131.702 134.198 136.04
    Cash and Short Term Investments 81.164 68.652 61.221 65.95 73.217
    Cash & Equivalents 81.164 68.652 61.221 65.95 73.217
    Total Receivables, Net 49.005 48.963 44.694 43.788 41.586
    Accounts Receivable - Trade, Net 49.005 48.963 44.694 43.084 40.83
    Total Inventory 19.068 16.815 14.657 13.183 13.976
    Prepaid Expenses 2.954 3.683 8.824 8.646 4.679
    Other Current Assets, Total 2.311 3.11 2.306 2.631 2.582
    Total Assets 189.022 176.378 168.159 171.43 172.798
    Property/Plant/Equipment, Total - Net 9.535 10.003 10.628 11.256 11.64
    Property/Plant/Equipment, Total - Gross 47.47 47.286 47.268 47.183 46.771
    Accumulated Depreciation, Total -37.935 -37.283 -36.64 -35.927 -35.131
    Goodwill, Net 19.441 19.441 19.976 19.976 19.976
    Intangibles, Net 5.395 5.565 5.706 5.852 4.992
    Other Long Term Assets, Total 0.149 0.146 0.147 0.148 0.15
    Total Current Liabilities 43.627 44.46 40.87 43.557 45.858
    Accounts Payable 9.17 8.15 7.823 8.847 8.82
    Accrued Expenses 32.603 34.247 31.253 32.876 35.076
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases
    Other Current Liabilities, Total 1.854 2.063 1.794 1.834 1.962
    Total Liabilities 95.198 96.55 93.611 96.924 99.824
    Total Long Term Debt 48.966 48.838 48.714 48.594 48.475
    Long Term Debt 48.966 48.838 48.714 48.594 48.475
    Capital Lease Obligations
    Other Liabilities, Total 2.605 3.252 4.027 4.773 5.491
    Total Equity 93.824 79.828 74.548 74.506 72.974
    Redeemable Preferred Stock 92.494 92.494 92.494 92.494 92.494
    Preferred Stock - Non Redeemable, Net 0 0 0 0 0
    Common Stock 0.116 0.116 0.115 0.114 0.114
    Additional Paid-In Capital 188.369 182.907 178.829 173.804 171.865
    Retained Earnings (Accumulated Deficit) -187.155 -195.689 -196.889 -191.906 -191.492
    Treasury Stock - Common -0.001 0 -0.007
    Total Liabilities & Shareholders’ Equity 189.022 176.378 168.159 171.43 172.798
    Total Common Shares Outstanding 116.36 116.109 115.38 113.705 113.668
    Total Preferred Shares Outstanding 0 0
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -30.197 -10.285 -49.284 -25.58 -29.979
    Cash From Operating Activities -17.893 -1.982 -30.263 -39.412 35.796
    Cash From Operating Activities 3.345 4.363 5.782 6.546 5.882
    Amortization 0.701 0.82 1.073 1.039 1.034
    Deferred Taxes 0 0 25.541
    Non-Cash Items 17.287 17.197 27.855 -1.364 14.715
    Cash Taxes Paid 0.181 0.169 0.208 0.308 0.859
    Changes in Working Capital -9.029 -14.077 -15.689 -20.053 18.603
    Cash From Investing Activities -2.66 -3.395 -4.555 0.504 -9.22
    Capital Expenditures -2.684 -3.47 -4.555 -2.218 -10.028
    Other Investing Cash Flow Items, Total 0.024 0.075 0 2.722 0.808
    Cash From Financing Activities -0.58 -3.352 61.561 62.859 -8.934
    Financing Cash Flow Items -1.19 -4.751 -14.478 -8.124 -4.914
    Issuance (Retirement) of Stock, Net 0.651 1.437 100.411 0.108 -4.017
    Issuance (Retirement) of Debt, Net -0.041 -0.038 -24.372 70.875 -0.003
    Net Change in Cash -21.133 -8.729 26.743 23.951 17.642
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -4.983 -30.197 -29.783 -21.357 -10.489
    Cash From Operating Activities -4.048 -17.893 -12.269 -13.228 -10.223
    Cash From Operating Activities 0.714 3.345 2.549 1.718 0.86
    Amortization 0.19 0.701 0.519 0.345 0.172
    Non-Cash Items 4.762 17.287 14.946 11.687 4.412
    Cash Taxes Paid 0 0.181 0.184 0.184 0
    Changes in Working Capital -4.731 -9.029 -0.5 -5.621 -5.178
    Cash From Investing Activities -0.677 -2.66 -0.951 -0.577 -0.148
    Capital Expenditures -0.677 -2.684 -0.975 -0.601 -0.172
    Other Investing Cash Flow Items, Total 0 0.024 0.024 0.024 0.024
    Cash From Financing Activities -0.004 -0.58 -0.646 -0.776 -1.036
    Financing Cash Flow Items 0 -1.19 -1.191 -1.191 -1.191
    Issuance (Retirement) of Stock, Net 0 0.651 0.574 0.437 0.166
    Issuance (Retirement) of Debt, Net -0.004 -0.041 -0.029 -0.022 -0.011
    Net Change in Cash -4.729 -21.133 -13.866 -14.581 -11.407
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Prescience Point Capital Management LLC Investment Advisor/Hedge Fund 6.5478 7602577 0 2022-06-15
    BlackRock Institutional Trust Company, N.A. Investment Advisor 6.1989 7197496 90897 2023-06-30 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 5.313 6168828 79021 2023-06-30 LOW
    Paradigm Capital Management, Inc. Investment Advisor/Hedge Fund 2.9975 3480400 29998 2023-06-30 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 2.8972 3363925 -385270 2023-06-30 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 2.0078 2331277 132740 2023-06-30 LOW
    Wright (Timothy R) Individual Investor 1.4739 1711324 0 2023-04-11
    Richmond Brothers, Inc. Investment Advisor 1.3664 1586500 -168627 2023-06-30 MED
    Millennium Management LLC Hedge Fund 1.229 1427032 1373237 2023-06-30 HIGH
    Cannell Capital, LLC Hedge Fund 0.9476 1100256 696594 2023-06-30 LOW
    Charles Schwab Investment Management, Inc. Investment Advisor 0.8533 990717 57265 2023-06-30 LOW
    D. E. Shaw & Co., L.P. Hedge Fund 0.8397 974930 443200 2023-06-30 MED
    Two Sigma Investments, LP Hedge Fund 0.8203 952496 672384 2023-06-30 HIGH
    Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.7781 903499 22649 2023-06-30 LOW
    Renaissance Technologies LLC Hedge Fund 0.7755 900385 20800 2023-06-30 HIGH
    Royce Investment Partners Investment Advisor/Hedge Fund 0.7542 875700 33700 2023-06-30 LOW
    Federated MDTA LLC Investment Advisor/Hedge Fund 0.7288 846250 -106958 2023-06-30 HIGH
    Kanen Wealth Management, LLC Investment Advisor/Hedge Fund 0.7191 834912 834912 2023-06-30 MED
    Morgan Stanley & Co. LLC Research Firm 0.6972 809462 460236 2023-06-30 MED
    Divisadero Street Capital Management, LP Investment Advisor/Hedge Fund 0.689 800000 800000 2023-06-30 HIGH

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    MiMedx Company profile

    About MiMedx Group Inc

    MiMedx Group, Inc. is utilizing amniotic tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts for multiple sectors of healthcare. The Company is focused on addressing the needs of patients with acute and chronic non-healing wounds, and a late-stage pipeline targeted at decreasing pain and improving function for patients with degenerative musculoskeletal conditions. The Company’s platform technologies include AmnioFix, EpiFix, EpiCord, AmnioCord and AmnioFill. Its AmnioFix and EpiFix are its tissue allografts derived from the amnion and chorion layers of the human placental membrane. The EpiCord and AmnioCord are tissue allografts derived from umbilical cord tissue. Its AmnioFill is a particulate product comprised of placental connective tissue matrix, derived from the placental disc and placental membranes.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, MiMedx Group Inc revenues increased 4% to $258.6M. Net loss applicable to common stockholders decreased 80% to $16.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Investigation, restatement and related decrease of 94% to $3.8M (expense), Loss on extinguishment of debt decrease from $8.2M (expense) to

    Equity composition

    Common Stock $.001 Par, 03/11, 100M auth., 64,331,910 issd., less 50,000 shs. in Treas. @ $25K. Insiders own approx. 18.35%.

    Industry: Bio Medical Devices

    1775 W Oak Commons Court, Ne
    MARIETTA
    GEORGIA 30062
    US

    Income Statement

    • Annual
    • Quarterly

    News

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023
    GBP

    UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?

    UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.

    10:48, 21 November 2023

    Gold Rises as Traders price-in Fed Rate Cuts

    Gold prices have declined despite a drop in Treasury yields and a weaker US Dollar. We look at the key drivers and technical levels for the gold price.

    13:17, 20 November 2023

    People also watch

    BTC/USD

    37,680.65 Price
    -0.230% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    XRP/USD

    0.61 Price
    -1.020% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    Gold

    2,038.54 Price
    -0.310% 1D Chg, %
    Long position overnight fee -0.0196%
    Short position overnight fee 0.0114%
    Overnight fee time 22:00 (UTC)
    Spread 0.30

    US100

    15,875.40 Price
    -0.730% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 1.8

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading